InterventionsHuman trial

OR09-07 Dynamic Proteomic Profiling in a 5-week Crossover Trial of Liraglutide in Obesity Reveals Weight-Dependent Myostatin Downregulation and Multi-Pathway Effects Beyond Weight Reduction

ENDO 2025 Abstract

The paper

Stefanakis K, Veeragandham P, de Pineres VG et al.

ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND

Presented at ENDO 2025

doi.org/10.1210/jendso/bvaf149.072